Further backing for HPV (human papillomavirus) screening:
This article was originally published in Clinica
Executive Summary
A team of Scandinavian cancer researchers has provided further evidence that screening for human papillomavirus (HPV) in conjunction with cervical Pap smears would improve detection of cervical cancer. There is a growing body of evidence suggesting that persistent HPV infection causes cancer, and the latest study, in the November 25 edition of the New England Journal of Medicine, researchers led Dr Keng-Ling Wallin of the Karolinska Institute in Stockholm found that a single positive finding of HPV DNA in a Pap smear confers an increased risk of cancer that is positive for the same virus.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.